ALINITY C TOTAL PROTEIN2.
ELENSAYOTOTALPROTEIN2SEUTILIZAPARALA DETERMINACIÓN CUANTITATIVA DEPROTEÍNAS TOTALES EN SUERO O PLASMAHUMANOSENELALINITYCSYSTEM. AGENTEDEDIAGNÓSTICOPARAUSOINVITRO. PARAUSOEXCLUSIVOENLABORATORIOSCLÍNICOSY DE GABINETE.
THE TOTALPROTEIN2 ASSAY IS USED FOR THE QUANTITATIVE DETERMINATION OF TOTAL PROTEINS IN HUMAN SERUM OR PLASMA IN THE LINITYCSYSTEM. DIAGNOSTICAGENTFORUSEINVITRO. FOR EXCLUSIVE USE IN CLINICAL AND CABINET LABORATORIES.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓNCUANTITATIVA DE PROTEÍNAS TOTALES.
- Trade Name (English)
- ASSAY FOR THE QUANTITATIVE DETERMINATION OF TOTAL PROTEINS.
- Analysis ID
- 1852R2021 SSA
- Registration Date
- November 16, 2021
- Name (Spanish)
- ABBOTT LABORATORIES DEMÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DEMÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ALINITY C TOTAL PROTEIN2. (ALINITY C TOTAL PROTEIN2.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1852R2021 SSA and manufactured by ABBOTT LABORATORIES DEMÉXICO, S.A. DE C.V.. The device was registered on November 16, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.